Literature DB >> 21172580

Emerging national trends in the management and outcomes of lower extremity peripheral arterial disease.

Michael S Hong1, Adam W Beck, Peter R Nelson.   

Abstract

BACKGROUND: In this study, we sought to analyze emerging national trends in the treatment of lower extremity peripheral arterial disease and associated outcomes.
METHODS: The Nationwide Inpatient Sample was queried between 2001 and 2007. Patients diagnosed with lower extremity atherosclerosis were selected by using the International Classification of Diseases, 9th Revision codes 440.20-440.24, resulting in an average of 307,000 annual hospitalizations. Within this group, we determined the annual number of lower extremity bypasses, endovascular interventions, and major and/or minor amputations (below-the- and/or above-the-knee amputation versus toe and/or foot amputation). Chi-square analysis was performed on discharge-weighted data to compare two periods (2001-2003 and 2004-2007) to determine changes in management and differences in outcome. Multivariate logistic regression was used to identify predictors of amputation.
RESULTS: Comparing the two periods, it was found that the average annual number of endovascular interventions increased by 78% (37,692 vs. 67,248, p < 0.001), and open lower extremity bypasses decreased by 20% (68,326 vs. 54,348, p < 0.001). Annually, the total number of interventions increased by 15% (106,018 vs. 121,596, p < 0.001), whereas the number of total amputations (59,693 vs. 50,254, p < 0.001), major amputations (39,543 vs. 31,043, p < 0.001), and minor amputations (20,150 vs. 19,211, p < 0.001) performed all significantly decreased. Diabetes was the leading predictor of amputation, especially those involving the toe and forefoot. After adjusting for age and comorbidities, African Americans were found to have a 2.4 times odds of amputation as compared with Caucasians, whereas those with Medicare or Medicaid had a 1.5 times odds as compared with those having private insurance or Health Maintenance Organization.
CONCLUSIONS: Between the periods examined, we observed that the treatment of lower extremity peripheral arterial disease has evolved with increased use of lesser invasive endovascular techniques and fewer open lower extremity bypasses. These trends are associated with fewer major lower extremity amputations. Significant socioeconomic disparities persist in amputation rates, with racial minorities and those with Medicare or Medicaid having higher odds of amputation. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21172580     DOI: 10.1016/j.avsg.2010.08.006

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  21 in total

1.  Trends in the incidence, treatment, and outcomes of acute lower extremity ischemia in the United States Medicare population.

Authors:  Donald T Baril; Kaushik Ghosh; Allison B Rosen
Journal:  J Vasc Surg       Date:  2014-04-24       Impact factor: 4.268

Review 2.  Physician and Patient Radiation Exposure During Endovascular Procedures.

Authors:  Andrew M Goldsweig; J Dawn Abbott; Herbert D Aronow
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-02

3.  Prior contralateral amputation predicts worse outcomes for lower extremity bypasses performed in the intact limb.

Authors:  Donald T Baril; Philip P Goodney; William P Robinson; Brian W Nolan; David H Stone; YouFu Li; Jack L Cronenwett; Andres Schanzer
Journal:  J Vasc Surg       Date:  2012-04-04       Impact factor: 4.268

4.  Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline.

Authors:  Derek LeRoith; Geert Jan Biessels; Susan S Braithwaite; Felipe F Casanueva; Boris Draznin; Jeffrey B Halter; Irl B Hirsch; Marie E McDonnell; Mark E Molitch; M Hassan Murad; Alan J Sinclair
Journal:  J Clin Endocrinol Metab       Date:  2019-05-01       Impact factor: 5.958

5.  Population-Based Trends in Amputations and Revascularizations for Peripheral Artery Disease From 1990 to 2009.

Authors:  Jeffrey J Nienaber; Carin Y Smith; Stephen Cha; Mateus Correa; Phillip G Rowse; Kent R Bailey; Manju Kalra
Journal:  Mayo Clin Proc       Date:  2022-02-15       Impact factor: 11.104

6.  Systemic inflammation as a predictor of clinical outcomes after lower extremity angioplasty/stenting.

Authors:  Kenneth DeSart; Kerri O'Malley; Bradley Schmit; Maria-Cecilia Lopez; Lyle Moldawer; Henry Baker; Scott Berceli; Peter Nelson
Journal:  J Vasc Surg       Date:  2015-06-06       Impact factor: 4.268

Review 7.  Cost-effectiveness of medical, endovascular and surgical management of peripheral vascular disease.

Authors:  Zaher Fanari; William S Weintraub
Journal:  Cardiovasc Revasc Med       Date:  2015-07-09

8.  Nationwide Trends in Hospital Outcomes and Utilization After Lower Limb Revascularization in Patients on Hemodialysis.

Authors:  Pranav S Garimella; Poojitha Balakrishnan; Ashish Correa; Priti Poojary; Narender Annapureddy; Kinsuk Chauhan; Achint Patel; Shanti Patel; Ioannis Konstantinidis; Lili Chan; Shiv Kumar Agarwal; Bernard G Jaar; Umesh Gidwani; Kunihiro Matsushita; Girish N Nadkarni
Journal:  JACC Cardiovasc Interv       Date:  2017-10-23       Impact factor: 11.195

9.  Femoropopliteal Artery Stent Thrombosis: Report From the Excellence in Peripheral Artery Disease Registry.

Authors:  Subhash Banerjee; Karan Sarode; Atif Mohammad; Osvaldo Gigliotti; Mirza S Baig; Shirling Tsai; Nicolas W Shammas; Anand Prasad; Mazen Abu-Fadel; Andrew Klein; Ehrin J Armstrong; Haekyung Jeon-Slaughter; Emmanouil S Brilakis; Deepak L Bhatt
Journal:  Circ Cardiovasc Interv       Date:  2016-02       Impact factor: 6.546

10.  Impact of Expanded Insurance Coverage on Racial Disparities in Vascular Disease: Insights From Massachusetts.

Authors:  Andrew P Loehrer; Alexander T Hawkins; Hugh G Auchincloss; Zirui Song; Matthew M Hutter; Virendra I Patel
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.